AIDS

Paediatric HIV: we are not done yet!

2021

This morning, at the 23rd International AIDS Conference, our collaborator Martina Penazzato provided a plenary speech on pediatric HIV. We met with her and asked for her thoughts on what urgent action we need to take to end AIDS in children.

Read More

Actual problems of HIV Infection: Mother and Child

2020

Penta has been invited to run a one-day session at the Republican Hospital of Infectious Diseases, St Petersburg conference on ‘Actual problems of HIV Infection: Mother and Child’ on Tuesday 15th September. 

Read More

A reason to SMILE – we reached Last Patient Last Visit

2020

Last Patient Last Visit (LPLV) completed for the Penta 17 Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (SMILE) trial.

The Penta sponsored trial,

Read More

ODYSSEY (Penta 20) trial plays an important role in the FDA approval of dolutegravir for children – a big step towards timely access to optimal ART for children

2020

Data from the ongoing P1093 and ODYSSEY (PENTA20) studies have led to the successful approval of ViiV Healthcare’s submission to the U.S. Food and Drug Administration (FDA) of the adult formulation for children weighing ≥20kg and dolutegravir (DTG) dispersible tablets for children of 4 weeks of age and older.

Read More

HIV-exposed and uninfected children and adolescents focus in this year’s International AIDS Conference

2020

Join the 6th Workshop on Children and Adolescents HIV-exposed and Uninfected (HEU) at 3pm (CEST) on 1st July 2020.

The workshop is part of the pre-conference programme of the International AIDS virtual conference 2020.

Read More

Penta at CROI 2020

2020

The annual Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 8 to 11 in Boston, Massachusetts.

CROI brings together top basic,

Read More

Penta at 10th International Workshop on HIV & Women

2020

The 10th International Workshop on HIV & Women is in Boston on 6 – 7 March 2020, just prior to CROI.

This is an outstanding opportunity for health care providers,

Read More

New publications from EPIICAL Consortium

2020

Just published – data on T & B cell memory and T cell function in early-treated children in the Journal of Immunology and AIDS.

Read More

Human Rights Day

2019

Today we celebrate Human’s Right Day: this year’s theme is “Youth Standing Up for Human Rights”.
School HIV-prevention campaigns in Africa are often designed to frighten children.

Read More

Picturing Health launches new video on adolescents with HIV

2019

Picturing Health has created the first video in a three part series of adolescent films about growing up with HIV. This series of short films tackles the issue of dealing with disclosure and the impact a child being told they are HIV positive.

Read More

World AIDS Day 2019: Communities make the difference

2019

The theme of this year’s World AIDS Day, which we commemorate today, is “Communities make the difference“. Today we highlight the role of communities in ensuring that AIDS remains at the top of the political agenda.

Read More

Universal Children’s Day

2019

Today, November 20th, is Universal Children’s Day. This year, we are celebrating in Cape Town, South Africa, where the EPIICAL 3rd General Assembly is being hosted.

Read More

CROI: Members of the EPIICAL team to attend in Seattle

2019

Seattle is gearing up for the 2019 edition of CROI next week. Held at Washington State Convention Center on 4th-7th March, the Conference on Retroviruses and Opportunistic Infections is an important event in the Penta calendar,

Read More

ILF: Advance procurement of paediatric drug formulations – Policy brief

2019

The many challenges of developing drugs appropriately formulated for children are compounded by a series of market factors that make these efforts costly and complex, discouraging drug manufacturers – especially generic drug manufacturers – from prioritizing investments in new paediatric treatment options.

Read More

World AIDS Day December 1st – What this means to PENTA

2018

Although the number of new HIV infections has continued to decline globally, and the overall level of HIV treatment is high, progress is far slower than what is required to reach the 2020 milestone of less than 500,000 new infections.

Read More